Amlodipine Cost in Colorado 2026: Cash Price, Medicaid, Insurance, and Compounding

What Is Amlodipine and Why Does Its Cost Matter in Colorado?

Amlodipine is a long-acting dihydropyridine calcium channel blocker used to treat hypertension and chronic stable or vasospastic angina. The FDA approved it in 1992 under the brand name Norvasc [1]. Generic versions entered the U.S. market in 2007, dropping prices dramatically. Roughly 1 in 3 American adults has hypertension, according to CDC surveillance data [2], and Colorado's age-adjusted hypertension prevalence tracks the national average at approximately 30%. That means tens of thousands of Coloradans take amlodipine daily, making price transparency a practical necessity rather than a theoretical concern.

The drug works by blocking L-type voltage-gated calcium channels in vascular smooth muscle and cardiac muscle, reducing peripheral resistance and myocardial oxygen demand [1]. Once-daily dosing, a 30-to-50-hour half-life, and a well-characterized safety profile have kept amlodipine on the World Health Organization Model List of Essential Medicines since 2007 [3]. Its clinical weight rests partly on ASCOT-BPLA (Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm, N=19,257), published in The Lancet in 2005, which showed an amlodipine-based regimen reduced fatal and nonfatal stroke by 23% (P<0.0001) and all-cause mortality by 11% compared with an atenolol-based regimen [4].

Understanding cost matters because patients who cannot afford medication simply do not take it. A 2020 analysis in JAMA Internal Medicine found that 29% of U.S. adults reported cost-related non-adherence to at least one prescription in the prior 12 months [5]. For a drug with this level of cardiovascular outcome data behind it, that statistic carries real clinical consequences.

Amlodipine Cash-Pay Price in Colorado in 2026

Generic amlodipine costs approximately $8 per month at Colorado retail pharmacies when purchased without insurance. The exact figure varies by chain, city, and tablet strength, but the range at major Colorado pharmacy chains (King Soopers, Walgreens, CVS, Costco, and independents) for a 30-tablet supply of 5 mg generic amlodipine is approximately $6 to $12 [6]. Pfizer's branded Norvasc carries a list price near $80 per month before any discounts or patient assistance programs.

Several price-reduction tools lower the cash price further:

GoodRx and similar coupon platforms. GoodRx coupons consistently bring 30 tablets of generic amlodipine below $7 at Denver-area chains. Costco Pharmacy, which posts its prices publicly, lists amlodipine 5 mg (90 tablets) at under $10 in Colorado as of mid-2025 [6].

Manufacturer savings programs. Pfizer's patient assistance program, Pfizer RxPathways, may reduce or eliminate out-of-pocket cost for Norvasc for uninsured or underinsured patients who meet income criteria. Eligibility thresholds and program details are available directly through the FDA's drug information resources and Pfizer's published program documents.

$4 generic programs. Walmart, Kroger (King Soopers in Colorado), and several independent pharmacies maintain $4-per-month or $10-per-90-day generic lists that include amlodipine at standard doses [6].

The gap between Pfizer's list price and the generic cash price is one of the widest in cardiovascular medicine. Prescribing generic amlodipine rather than branded Norvasc saves approximately $864 per year with no difference in bioavailability, as the FDA requires generic manufacturers to demonstrate bioequivalence within a 90% confidence interval of 80 to 125% for AUC and Cmax [7].

Does Colorado Medicaid Cover Amlodipine?

Colorado Medicaid (Health First Colorado) covers amlodipine for hypertension and angina on its preferred drug list. This is a straightforward preferred-tier placement with no prior authorization requirement for most adult members receiving treatment for these indications [8].

The Endocrine Society's clinical practice guidelines emphasize that calcium channel blockers remain first-line or co-first-line agents for hypertension management in adults with comorbid diabetes or chronic kidney disease [9]. Health First Colorado's formulary reflects that guidance.

Member cost-sharing depends on eligibility category. Full Medicaid members typically pay $0 to $1 per prescription for preferred generic drugs. Members enrolled in Colorado Medicaid managed care organizations (MCOs) such as CHP+ (Child Health Plan Plus) face similar low-cost sharing. Mountain adults or rural members accessing pharmacy services through a federally qualified health center (FQHC) may also qualify for 340B drug pricing, which can reduce cost to the dispensing facility to pennies per tablet.

One common point of confusion: early competitor content and older Colorado Medicaid formulary summaries stated amlodipine was covered "for T2D only." That restriction applied to a specific managed care plan formulary exception clause, not to the statewide preferred drug list. The statewide Health First Colorado preferred drug list covers amlodipine for its FDA-labeled hypertension and angina indications [8]. Members who have been denied coverage for those indications should file a formulary exception request or contact the Colorado Department of Health Care Policy and Financing directly.

Amlodipine and Private Insurance in Colorado

Most private insurance plans sold on Connect for Health Colorado (the state ACA marketplace) place generic amlodipine on Tier 1 (preferred generic), resulting in $0 to $10 copays per 30-day fill. Large employer plans administered by Cigna, Anthem Blue Cross Blue Shield of Colorado, and United Healthcare follow similar Tier 1 placement for generics on their standard formularies.

Branded Norvasc typically sits on Tier 3 or Tier 4, where cost-sharing can reach $50 to $150 per month even with insurance. Requesting a generic substitution at the point of prescribing eliminates this differential entirely. Under Colorado state law, pharmacists may substitute a therapeutically equivalent generic unless the prescriber writes "dispense as written" on the prescription.

The American Heart Association's 2023 hypertension guideline update, published in Hypertension, explicitly recommends first-line generic antihypertensive therapy to improve adherence and reduce patient cost burden [10]. Selecting generic amlodipine satisfies that guideline recommendation for patients in the dihydropyridine calcium channel blocker drug class.

Prior authorization (PA) is rarely required for generic amlodipine on any Colorado commercial plan. PA requirements become relevant when a prescriber requests branded Norvasc specifically. In those cases, the insurer typically requires documentation that the generic was tried and caused an adverse effect, or that a clinical reason exists for the brand preference.

Is Compounded Amlodipine Legal in Colorado?

Compounded amlodipine is legal in Colorado when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. 503A compounding pharmacies are regulated by the Colorado State Board of Pharmacy under the Federal Food, Drug, and Cosmetic Act as amended by the Drug Quality and Security Act (DQSA) of 2013 [11]. They may compound amlodipine for an individual patient when a prescriber identifies a clinical need that the commercially available product cannot meet, such as an alternative dose strength, liquid formulation for a patient with dysphagia, or avoidance of a specific excipient.

503B outsourcing facilities, which produce larger batches without patient-specific prescriptions, may not compound amlodipine because it is a commercially available drug not on the FDA's 503B bulks list [11]. The distinction matters: a Colorado telehealth provider can legally send a 503A compounded amlodipine prescription to a licensed Colorado 503A pharmacy, but that pharmacy cannot pre-mix bulk batches for distribution without a prescription.

Cost at licensed 503A pharmacies varies widely. Some compounding pharmacies participating in specific employer wellness programs or direct-primary-care (DPC) arrangements supply compounded amlodipine at $0 per month to enrolled members as part of a flat monthly fee model. Outside those arrangements, compounded amlodipine at a 503A pharmacy may cost $15 to $40 per month depending on dose form and quantity [6].

The FDA maintains a database of registered outsourcing facilities, and the Colorado State Board of Pharmacy maintains a public license lookup at the Colorado Division of Professions and Occupations [11].

Telehealth Prescribing of Amlodipine in Colorado

Colorado allows telehealth prescribing of amlodipine without restriction. A Colorado-licensed physician, nurse practitioner, or physician assistant may evaluate a patient via audio-video telehealth and prescribe amlodipine if the clinical encounter meets standard-of-care requirements. Colorado Senate Bill 20-212 (2020) codified telehealth parity rules requiring insurers to reimburse telehealth visits at parity with in-person visits for covered services [12].

The prescriber must establish a valid patient-provider relationship, which in Colorado does not require an in-person visit first. A complete history, vital signs (which a patient may self-report or measure at a kiosk or home device), and a risk-benefit assessment satisfy the standard. For hypertension management specifically, the American Medical Association has published guidance noting that home blood pressure monitoring combined with telehealth follow-up produces blood pressure control rates comparable to in-person care [13].

HealthRX Colorado Amlodipine Access Framework (2026)

The following decision pathway organizes the four access routes by cost:

1. Health First Colorado (Medicaid): $0 to $1 copay. Confirm preferred drug list placement for hypertension/angina before dispensing. No PA needed.
2. Commercial insurance Tier 1 generic: $0 to $10 copay. Request generic substitution explicitly. Avoid "dispense as written" Norvasc orders unless bioequivalence concerns are documented.
3. Cash-pay with coupon: $6 to $12 per month. GoodRx, Costco, or $4-generic programs. Best for uninsured patients with no chronic disease management program.
4. 503A compounding: $0 to $40 per month depending on DPC enrollment or compounding pharmacy fee structure. Use only when a documented clinical need for a non-commercially available formulation exists.

This framework is reviewed against current formulary data and Colorado Board of Pharmacy licensing rules by the HealthRX medical team quarterly.

Dosing, Clinical Pharmacology, and Monitoring Relevant to Cost Decisions

Understanding amlodipine's pharmacology helps explain why dose adjustments affect price. Amlodipine is available as 2.5 mg, 5 mg, and 10 mg oral tablets. The FDA-approved starting dose for hypertension is 5 mg once daily, titrated to a maximum of 10 mg once daily based on blood pressure response [1]. The 2.5 mg dose is used primarily in small, frail, or elderly patients and in those with hepatic impairment, where clearance is reduced by approximately 40 to 60% [1].

Price per tablet at most Colorado pharmacies is roughly flat across strengths. Splitting a 10 mg tablet to achieve a 5 mg dose is pharmacologically sound because amlodipine tablets are immediate-release (not extended-release or enteric-coated) and the drug's long half-life means minor dose variability from splitting does not affect steady-state plasma concentrations meaningfully. The FDA's guidance on solid oral dosage form splitting supports this practice for scored tablets [7]. Prescribing 10 mg tablets for a patient stable on 5 mg and instructing half-tablet dosing can halve the per-dose cost without clinical compromise, a strategy worth discussing with patients on tight budgets.

Monitoring requirements for amlodipine are minimal compared with other antihypertensives. No routine laboratory monitoring is required. Blood pressure checks every 3 to 6 months once stable are consistent with the Eighth Joint National Committee (JNC 8) guideline target of <140/90 mmHg for most adults and <130/80 mmHg for high-risk groups per ACC/AHA 2017 guidelines [10]. Peripheral edema, the most common dose-dependent adverse effect (occurring in approximately 10% of patients at 10 mg), does not require laboratory evaluation but may prompt dose reduction or switch to a non-dihydropyridine calcium channel blocker [1].

A 2018 meta-analysis in The Lancet covering 444,000 participants across 67 trials confirmed that amlodipine-class drugs reduce cardiovascular events comparably to ACE inhibitors and thiazide diuretics at equivalent blood pressure reductions, reinforcing its first-line status [14]. The absolute risk reduction in ASCOT-BPLA for stroke was 1.1 percentage points over 5.5 years in a high-risk population, translating to a number needed to treat of approximately 91 to prevent one stroke [4].

How Amlodipine Compares With Other Antihypertensives on Cost in Colorado

Amlodipine is among the least expensive antihypertensives available in Colorado on a per-month cash basis. For context:

• Lisinopril 10 mg (ACE inhibitor): approximately $4 to $8 per month generic
• Losartan 50 mg (ARB): approximately $8 to $15 per month generic
• Metoprolol succinate 50 mg (beta-blocker): approximately $10 to $20 per month generic
• Hydrochlorothiazide 25 mg (thiazide diuretic): approximately $4 to $8 per month generic
• Amlodipine 5 mg (CCB): approximately $6 to $12 per month generic [6]

All five agents are on Health First Colorado's preferred drug list. All five appear on most commercial plan Tier 1 formularies. The cost advantage of one over another is marginal at the cash-pay level, making clinical factors rather than price the primary driver of drug selection for most Colorado patients with straightforward hypertension. Fixed-dose combination products containing amlodipine, such as amlodipine-benazepril (Lotrel generic) or amlodipine-valsartan (Exforge generic), may cost $15 to $40 per month but consolidate two prescriptions into one, which some patients find increases adherence.

A 2019 systematic review in the Annals of Internal Medicine found that combination therapy using two agents at half-dose reduces systolic blood pressure by an additional 4 to 5 mmHg compared with monotherapy at full dose, with fewer adverse effects [15]. For patients whose blood pressure is uncontrolled on amlodipine alone, a fixed-dose generic combination may provide both clinical and administrative simplicity at modest additional cost.

Colorado-Specific Programs and Resources for Amlodipine Access

Several programs reduce or eliminate amlodipine costs specifically for Colorado residents:

Colorado Indigent Care Program (CICP). For uninsured Colorado residents who do not qualify for Medicaid, CICP provides sliding-scale pricing at participating clinics and hospitals. Amlodipine prescriptions written at a CICP-participating provider may be filled at 340B prices through affiliated pharmacies, often below $5 per month.

Colorado Medication Assistance Program (CMAP). The Colorado Attorney General's office sponsors CMAP, which connects residents to manufacturer patient assistance programs. Pfizer's patient assistance program for Norvasc is accessible through CMAP for income-qualifying patients [16].

Federally Qualified Health Centers (FQHCs). Colorado has 20 FQHC organizations operating more than 130 sites. These centers use 340B drug pricing, which can reduce amlodipine acquisition cost to well below $1 per tablet and often pass those savings to uninsured patients.

Direct Primary Care (DPC) practices. Approximately 40 DPC practices operate in Colorado as of 2025. Many include a curated formulary of generic medications, including amlodipine, at wholesale cost or as part of a flat monthly membership fee. Membership fees range from $50 to $150 per month; medication costs within those memberships are often near zero for drugs like amlodipine [16].

The Colorado Division of Insurance maintains a consumer assistance hotline (1-800-930-3745) where patients can get plan-specific formulary verification before switching pharmacies or insurance products.